FDA Withdraws Approval for Multiple Myeloma Drug Pepaxto Over Safety and Efficacy Concerns
The US Food and Drug Administration (FDA) has announced its final decision to withdraw approval...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity